Cancer Research Translational Initiative Exceptional Translational Research Award
Open funding opportunity
Deadline
LOIs due Sept. 22, 2023
The Masonic Cancer Center's Cancer Research Translational Initiative (CRTI) Exceptional Translational Research Award objective is to identify and fund the outstanding translational research projects that will lead to sustainable high impact external funding. Translation should be in any area of Cancer Research that applies or accelerates discovery into testing in clinical or population settings.